Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Artelo Biosciences Inc

Current price
1.32 USD +0.015 USD (+1.15%)
Last closed 1.28 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 922 242 USD
Yield for 12 month -54.02 %
21.11.2021 - 28.11.2021

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Address: 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

16.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 440 756 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -37.09 %
PEG Ratio
Return On Equity TTM -59.63 %
Wall Street Target Price 16.67 USD
Revenue TTM
Book Value 3.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -3.14 USD
Diluted Eps TTM -3.14 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ARTL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 10.08.2022
Dividend Date 21.06.2019

Stock Valuation ARTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.59
Price Book MRQ 0.4188

Financials ARTL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ARTL

For 52 weeks

1.15 USD 2.9 USD
50 Day MA 1.51 USD
Shares Short Prior Month 20 190
200 Day MA 1.57 USD
Short Ratio 0.86
Shares Short 14 538
Short Percent 0.45 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics